Prostate cancer in the currently occupies at 1 - 2 nd place in the structure of morbidity and 2 - 3rd place in the structure of mortality from cancer among men in most developed countries. Current methods of diagnosis and treatment of prostate cancer can provide early detection and effective treatment of this disease.
Cancer of the prostate (FPW) - one of the most frequent malignant tumors in men middle-aged and older. More than 80% of cases is under the age of 65. Currently in the USA FPW - this is the most common form of cancer among men in 1996 identified 317 000 new patients who have died - 41 400.
The likelihood of the development of microscopic FPW for life is 30%, while the probability of death - 3%. A great influence on the incidence has geographical location and race. The highest incidence of more than 100 per 100 000 population, marked by black men in the U.S., and they FPW develops at a younger age. The low incidence is found in Asia and Africa, where it is ten times lower than in North America and Northern Europe.
Important is the fact that the migration of Chinese and Japanese in the U.S. leads to a considerable increase in the incidence of these groups. Thus, when the incidence in China 1,2 - 1,7 per 100 000 population, the frequency of cancer among the Chinese who moved to the U.S., reaching 28 per 100 000 population, which spoke of the impact of environmental factors and life.
However, the frequency of latent FPW virtually identical in all populations studied, and found at autopsy in 10 - 15% of men who died of various causes, while those over 60 years this figure reaches 30%. FPW incidence in Russia is 9, 3 per 100 000 population (world standard, 1995).
In addition to age, an important risk factor for FPW is heredity. In the presence of prostate cancer among blood relatives the risk increases by 2 - 3 times, about 9% of the FPW is due to genetic causes. They noted the relationship between illness and consumption of foods rich in animal fats. Risk factors are overweight. Geographical prevalence of prostate cancer correlates with the incidence of malignant tumors of the breast and colon cancer.
In the diet of residents of Asian countries, where prevalence is low FPW, contains a lot of vitamin A and estrogens of plant origin, which neutralize effect of androgens on the prostate gland. For other data, has a protective effect of vitamin E reduces the risk of cancer by 35%. We study the role of infectious factors, such as herpes virus, cytomegalovirus.
It was found that patients with prostate cancer, sexually transmitted diseases are sick, their wives are sick of cervical cancer. It is shown that over 50% of prostate tumors containing human papillomavirus. The question of increased risk in people who have contact with cadmium, the nuclear power plants.
Important role in the development of hormonal status plays FPW. Testosterone and its more powerful metabolite dihydrotestosterone, formed in the tissue of the prostate by the enzyme 5a-reductase, necessary for normal growth and development of the prostate. Hormone hypothesis development FPW confirmed hormonal success, the possibility of cancer in animals as a result of long-term exposure to androgens.
In addition, prostate cancer does not develop in men castrated prior to the completion of sexual development, and very rarely - if insufficient enzyme 5a-reductase.
Pathological Anatomy.
Up to 70% of the FPW is developing in the peripheral zone, about 10 - 15% of tumors located in the central zone, while in other cases - in the transitional zone of the prostate. Approximately 15 - 30% of men older than 50 years show FPW, which has no clinical manifestations or latent cancer. Typically, this small, well-differentiated tumors less than 0.5 cm3, with the increase is accompanied by loss of differentiation characteristics. In addition, it was found that 10% of tumors with a small amount of 0,5% from 1 cm3 invaziruyut in the capsule.
Recently, for the histological classification is widely used Gleason (1966), five different gradations, and based on the extent of the tumor cells in a distinct ferruginous structures.
Graduation 1: a tumor composed of small uniform glands with minimal changes in the nuclei.
Graduation 2: a tumor composed of clusters of glands are still separated by stroma, but located close to each other.
Graduation 3: The tumor consists of glands of different size and structure and, as a rule, infiltrative stromal and surrounding tissue.
Graduation 4: The tumor is composed of clearly atypical cells and infiltrative surrounding tissue.
Graduation 5: tumor is an undifferentiated layers of atypical cells.
Because the FPW is often heterogeneous structure, for the calculation of points on the Gleason summarize two of the greatest importance for graduation. The resulting number of points is an important prognostic sign. Patients with scores of less than 4 FPW metastatic to the 2, 1% per year, between 5 and 7 - to 5.4% and a 7 - to 13,5% of cases.
The probability of local spread of tumor for 10 years, depending on the number of points on the Gleason presented in the table.
Clinic.
Current possibilities of diagnosis FPW identify disease in its early stages, but more than 50 - 70% of patients at the time of diagnosis reveal III - IV stage of disease. FPW a long time may be asymptomatic, the appearance of clinical manifestations often shows far gone process. One of the first symptoms are a violation of an act of urination: a fast, sometimes painful urination, vyalaya stream, difficulty in beginning urination, a feeling of incomplete emptying of the bladder in 20% of cases there is an acute delay in the urine, although possible and urinary incontinence. In addition, more pronounced in the local spread of tumor may occur gematuriya, pain in the perineum and the lobkom, symptoms sdavleniya ureter, urinary infection, impotence, gematospermiya.
Locally distributed FPW can affect the distal rectum department and cause symptoms such as constipation, tenezmy and bleeding from the rectum. In the presence of metastases in regional lymph nodes may cause edema scrotum, lower extremities. Characteristic gematogennymi metastases for FPW are metastases in the pelvic bones, lumbo-sacral spine, with the possible development of paraplegia.
Diagnosis.
Paltseva study of the prostate through the rectum is a simple, cheap and quite effective method of diagnosing prostate cancer. The sensitivity of this method is 80%, and specificity to 50%. Signs of the FPW are rocky areas of tissue density in the prostate, its asymmetry, immobility due to the seam with the surrounding tissues, palpiruemye seminal vesicles (a symptom of “bull horns”). Differential diagnosis should be carried out with stones, prostate adenoma, particularly in the fibrous form granulematoznym prostatitis, tuberculosis. The most marked underestimation of the stage, because small, located in the front offices of prostate tumors are usually not palpiruyutsya. When cytological study of biopsy of the prostate nodular education, identified with the finger rectally study, 40 - 50% are cancer.
Studies in recent years suggest that a laboratory is essential to define the serum prostate specific antigen (PSA). PSA - this glycoprotein involved in the diluted semen. In raising its level of above 6 ng / ml in one third of men find FPW. PSA in serum in the form of free and associated with a1-himotripsinom forms. In patients with adenoma of the prostate is dominated by increased levels of free PSA, and cancer patients - related. Determination of levels of PSA - this is the most effective method of identifying FPW during mass surveys, the diagnostic value of the method increases when used in combination with finger rectal study. In addition, to improve the clinical relevance of this method is defined indicators such as index or PSA density (the correlation between serum levels of PSA and the size of the prostate, with PSA less than 0.15, the index tumor, probably clinically insignificant), the age norms (the so - as PSA levels rise with age). Moreover, noting the relationship of PSA and the incidence of breast cancer patients: PSA levels are 10 - 20 ng / ml showed germination capsules, levels above 40 ng / ml - the existence of metastases. It turned out that the definition of multiple levels of PSA can be used to assess the effectiveness of treatment. Convincing data on the importance of PSA suggest that with increasing levels of PSA and the lack of pathology in the finger rectally study shows the implementation of transrektalnoy ultrasonic tomography prostate and, if necessary, multifokalnoy puncture biopsy of the prostate.
An important diagnostic method is transrektalnoe ultrasound of the prostate, allowing the identification of tumor up to 1 cm in diameter. With UZT assess the prevalence of bladder cancer, germination in the capsule, the relationship with bladder and rectum. The most valuable method is the ability to monitor the advancement of the needle puncture biopsy in the performance. Magnetic resonance imaging and computed tomography are also used to study prostate, but their effectiveness does not exceed UZT results and the simplicity and safety of ultrasound allows deservedly take its lead method.
So far there is no single opinion on the feasibility of a screening FPW. The existence of simple survey techniques (finger rectal study, the definition of PSA), the identification of tumors at an early stage where possible to completely cure the patient, certainly an advantage of screening. However, there is also the view that early detection of hidden running FPW is not appropriate. Prolonged life expectancy of patients with asymptomatic FPW compared with clinical may be due to slow tumor growth, and its early detection can lead to giperdiagnostike and giperlecheniyu. Older men positive effect of screening may not be as significant as that of younger patients, as well as the likelihood of significant progression of the disease from them below. In addition, the effectiveness of screening for a reduction in mortality has not been proven.
Treatment.
In the treatment of FPW is now used by virtually all the special effects techniques used in oncology - surgical, radiation, hormonal, medicinal. The choice of treatment depends primarily on the incidence of bladder cancer.
In the treatment of localized FPW (T1-2) uses the following methods: temporizing tactics, radiation therapy, surgical treatment. Temporizing tactic often used in stage T1 (tumor not detected clinically, discovered by accident when microscopic examination), in patients older forms with well differentiated tumors. In stage T1a (tumor takes less than 5% rezitsirovannogo material) picture of the progressive disease develops in over 10 years at 6% of patients. As a regular definition of PSA levels.
However, localized forms of prostate cancer is more common active therapeutic approach, including the use of radiation therapy or surgery.
When radiation therapy patients FPW most commonly used static mnogopolnoe and / or rotating teleirradiation, rarely - interstitial - with the use of radioactive isotopes (gold-198, iodine-125). When the effects of interstitial radiotherapy in the first phase of the implementation of appropriate pelvic limfadenektomii. Shown better results when combined with radiation therapy with local microwave hyperthermia. When radiation therapy is very important most accurate topometriya, as well as taking stock of adequate doses - at least 65 - 70 Gy. Such potential complications of radiation therapy as proktity and cystitis occur in 5 - 20%, urinary incontinence, impotence, and 30%. In recent proliferation of so-called conformal radiation therapy, which is using new technology provides more accurate beam focusing. In general, the results of radiotherapy are comparable with the results of surgical treatment and are discussed in detail in a special article of this issue.
According to most urologists, the best method of treatment is limited FPW Radical prostatektomiya. This operation is useful in cases where the patient’s life expectancy is at least 10 years. This operation is performed, usually pozadilobkovym access involves removal of the prostate, together with the capsule, seminal vesicles, prostatic part of urethra, bladder neck, regional lymph nodes. The advantages of radical prostatektomii are the complete removal of the tumor, the exact definition of stage of disease, concomitant treatment of prostate adenoma, reliable suppression of PSA levels below the sensitivity of the qualitative analysis. The disadvantages include postoperative mortality (0 to 5%) and complications such as impotence (50 - 70%), anastomotic stricture uretralnogo (5 - 17%), urinary incontinence (3 - 36%).
It also examines the local impact of such methods as cryotherapy, laser therapy, treatment of high-intensity focused ultrasound. The preliminary results allow to consider the proposed method is effective.
In the treatment of place-distributed FPW (stage T3), in which the tumor sprouts from the capsule gland, preferred methods of radiation exposure in combination with hormonal. There have been reports on the preoperative hormonal (usually maximal androgenic blockade), which leads to the reduction of endocrine stage and makes possible the implementation of the radical operation (this method is under study).
Most of the patients at the time of diagnosis FPW have distant metastases, according to some sources, this figure reaches 50 - 70%. Unlike the limited, local spread of 70% of patients with disseminated FPW die within 5 years. Since 1941, when Huggins and Hodges first described the effect of surgical castration (bilateral orhidektomii) and estrogen therapy in patients with metastatic prostate cancer, androgen blockade is the main principle of treatment of patients with metastatic tumor processes. The use of estrogens is accompanied by a number of serious complications, such as an increase in blood coagulability with venous thrombosis, cardiovascular disorders. Widespread antiandrogens, is preferable to direct action, ie, by blocking androgen receptors specifically in the tissue of the prostate. The gold standard in the treatment of metastatic FPW is now considered a complete or maximal androgenic blockade, consisting of surgical castration or medication, which is achieved by using drug-hormone analogues rilizing lyuteoniziruyuschego pituitary hormone (zoladeks) in combination with antiandrogen direct action (kasodeks, flyutamid) . The problem of androgenic blockade is discussed by us in a special article of this issue.
The failure of hormonal FPW attributed partly to the fact that approximately 20 - 30% of patients with tumors initially sensitive to endocrine treatment, but in other cases gormonorezistentnost develops after an average of 36 months after starting treatment. In such cases, resort to polychemotherapy, the effectiveness of which is 20 - 40%, the most effective drugs are adriamycin, and platinum derivatives. Also for the treatment of disseminated FPW used drugs such as suramin, an inhibitor of epidermal growth factor and Insulin; gormonotsitostatik - estramustina phosphate; liarozol - medication, delaying the destruction of Retinoic acid and thus prolonged the antiproliferative effect of retinoic acid. To deal with bone pain was successfully applied metastron (aqueous solution of chloride of strontium-89), introduced the patient intravenously 1 every 3 - 6 months.
Thus, the use of the whole range of therapeutic interventions allows hope to achieve favorable results in treating patients FPW in various stages of the disease, but a number of unresolved issues proves the need for further study on this issue.